The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy. They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial – their approval does not mean that the therapy is 'safe' or effective, only that the trial may be conducted.
The global Clinical Trials market size is expected to reach US$ 62370 million by 2029, growing at a CAGR of 4.1% from 2023 to 2029. The market is mainly driven by the significant applications of Clinical Trials in various end use industries. The expanding demands from the Interventional, Observational and Expanded Access,, are propelling Clinical Trials market. Phase I, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Phase II segment is estimated at % CAGR for the next seven-year period.
The industry's leading producers are Parexel, PRA Health and LabCorp (Covance), which accounted for 4.94%, 7.25% and 11.81% of revenue in 2019, respectively. By region, North America has the highest share of income, at more than 39 percent.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Clinical Trials, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Clinical Trials market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Clinical Trials market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Clinical Trials sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Clinical Trials covered in this report include Quintiles IMS, Paraxel International Corporation, Charles River Laboratories, ICON plc, SGS SA, Pharmaceutical Product Development, LLC, Wuxi AppTec Inc., PRA Health Sciences and Chiltern International Ltd., etc.
The global Clinical Trials market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
- Quintiles IMS
- Paraxel International Corporation
- Charles River Laboratories
- ICON plc
- SGS SA
- Pharmaceutical Product Development, LLC
- Wuxi AppTec Inc.
- PRA Health Sciences
- Chiltern International Ltd.
- INC Research
Global Clinical Trials market, by region:
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, UK, Italy, etc.)
- Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
- South America (Brazil, etc.)
- Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Clinical Trials market, Segment by Type:
- Phase I
- Phase II
- Phase III
- Phase IV
Global Clinical Trials market, by Application
- Interventional
- Observational
- Expanded Access
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Clinical Trials companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Clinical Trials
1.1 Clinical Trials Market Overview
1.1.1 Clinical Trials Product Scope
1.1.2 Clinical Trials Market Status and Outlook
1.2 Global Clinical Trials Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Clinical Trials Market Size by Region (2018-2029)
1.4 Global Clinical Trials Historic Market Size by Region (2018-2023)
1.5 Global Clinical Trials Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Clinical Trials Market Size (2018-2029)
1.6.1 North America Clinical Trials Market Size (2018-2029)
1.6.2 Europe Clinical Trials Market Size (2018-2029)
1.6.3 Asia-Pacific Clinical Trials Market Size (2018-2029)
1.6.4 Latin America Clinical Trials Market Size (2018-2029)
1.6.5 Middle East & Africa Clinical Trials Market Size (2018-2029)
2 Clinical Trials Market by Type
2.1 Introduction
2.1.1 Phase I
2.1.2 Phase II
2.1.3 Phase III
2.1.4 Phase IV
2.2 Global Clinical Trials Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Clinical Trials Historic Market Size by Type (2018-2023)
2.2.2 Global Clinical Trials Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Clinical Trials Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Clinical Trials Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Clinical Trials Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Clinical Trials Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Clinical Trials Revenue Breakdown by Type (2018-2029)
3 Clinical Trials Market Overview by Application
3.1 Introduction
3.1.1 Interventional
3.1.2 Observational
3.1.3 Expanded Access
3.2 Global Clinical Trials Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Clinical Trials Historic Market Size by Application (2018-2023)
3.2.2 Global Clinical Trials Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Clinical Trials Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Clinical Trials Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Clinical Trials Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Clinical Trials Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Clinical Trials Revenue Breakdown by Application (2018-2029)
4 Clinical Trials Competition Analysis by Players
4.1 Global Clinical Trials Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Clinical Trials as of 2022)
4.3 Date of Key Players Enter into Clinical Trials Market
4.4 Global Top Players Clinical Trials Headquarters and Area Served
4.5 Key Players Clinical Trials Product Solution and Service
4.6 Competitive Status
4.6.1 Clinical Trials Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Quintiles IMS
5.1.1 Quintiles IMS Profile
5.1.2 Quintiles IMS Main Business
5.1.3 Quintiles IMS Clinical Trials Products, Services and Solutions
5.1.4 Quintiles IMS Clinical Trials Revenue (US$ Million) & (2018-2023)
5.1.5 Quintiles IMS Recent Developments
5.2 Paraxel International Corporation
5.2.1 Paraxel International Corporation Profile
5.2.2 Paraxel International Corporation Main Business
5.2.3 Paraxel International Corporation Clinical Trials Products, Services and Solutions
5.2.4 Paraxel International Corporation Clinical Trials Revenue (US$ Million) & (2018-2023)
5.2.5 Paraxel International Corporation Recent Developments
5.3 Charles River Laboratories
5.3.1 Charles River Laboratories Profile
5.3.2 Charles River Laboratories Main Business
5.3.3 Charles River Laboratories Clinical Trials Products, Services and Solutions
5.3.4 Charles River Laboratories Clinical Trials Revenue (US$ Million) & (2018-2023)
5.3.5 ICON plc Recent Developments
5.4 ICON plc
5.4.1 ICON plc Profile
5.4.2 ICON plc Main Business
5.4.3 ICON plc Clinical Trials Products, Services and Solutions
5.4.4 ICON plc Clinical Trials Revenue (US$ Million) & (2018-2023)
5.4.5 ICON plc Recent Developments
5.5 SGS SA
5.5.1 SGS SA Profile
5.5.2 SGS SA Main Business
5.5.3 SGS SA Clinical Trials Products, Services and Solutions
5.5.4 SGS SA Clinical Trials Revenue (US$ Million) & (2018-2023)
5.5.5 SGS SA Recent Developments
5.6 Pharmaceutical Product Development, LLC
5.6.1 Pharmaceutical Product Development, LLC Profile
5.6.2 Pharmaceutical Product Development, LLC Main Business
5.6.3 Pharmaceutical Product Development, LLC Clinical Trials Products, Services and Solutions
5.6.4 Pharmaceutical Product Development, LLC Clinical Trials Revenue (US$ Million) & (2018-2023)
5.6.5 Pharmaceutical Product Development, LLC Recent Developments
5.7 Wuxi AppTec Inc.
5.7.1 Wuxi AppTec Inc. Profile
5.7.2 Wuxi AppTec Inc. Main Business
5.7.3 Wuxi AppTec Inc. Clinical Trials Products, Services and Solutions
5.7.4 Wuxi AppTec Inc. Clinical Trials Revenue (US$ Million) & (2018-2023)
5.7.5 Wuxi AppTec Inc. Recent Developments
5.8 PRA Health Sciences
5.8.1 PRA Health Sciences Profile
5.8.2 PRA Health Sciences Main Business
5.8.3 PRA Health Sciences Clinical Trials Products, Services and Solutions
5.8.4 PRA Health Sciences Clinical Trials Revenue (US$ Million) & (2018-2023)
5.8.5 PRA Health Sciences Recent Developments
5.9 Chiltern International Ltd.
5.9.1 Chiltern International Ltd. Profile
5.9.2 Chiltern International Ltd. Main Business
5.9.3 Chiltern International Ltd. Clinical Trials Products, Services and Solutions
5.9.4 Chiltern International Ltd. Clinical Trials Revenue (US$ Million) & (2018-2023)
5.9.5 Chiltern International Ltd. Recent Developments
5.10 INC Research
5.10.1 INC Research Profile
5.10.2 INC Research Main Business
5.10.3 INC Research Clinical Trials Products, Services and Solutions
5.10.4 INC Research Clinical Trials Revenue (US$ Million) & (2018-2023)
5.10.5 INC Research Recent Developments
6 North America
6.1 North America Clinical Trials Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Clinical Trials Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Clinical Trials Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Clinical Trials Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Clinical Trials Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Clinical Trials Market Dynamics
11.1 Clinical Trials Industry Trends
11.2 Clinical Trials Market Drivers
11.3 Clinical Trials Market Challenges
11.4 Clinical Trials Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
